ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $865,000 | -87.1% | 15,030 | -85.7% | 0.00% | -85.2% |
| Q1 2015 | $6,692,000 | +0.2% | 105,103 | -2.8% | 0.03% | -6.9% |
| Q4 2014 | $6,676,000 | +58.7% | 108,125 | -0.2% | 0.03% | +61.1% |
| Q3 2014 | $4,206,000 | +13.0% | 108,312 | +0.3% | 0.02% | +20.0% |
| Q2 2014 | $3,722,000 | -5.0% | 108,029 | +19.2% | 0.02% | -16.7% |
| Q1 2014 | $3,916,000 | -20.4% | 90,625 | -26.6% | 0.02% | -10.0% |
| Q4 2013 | $4,921,000 | +4.1% | 123,529 | -1.9% | 0.02% | -4.8% |
| Q3 2013 | $4,728,000 | +3.3% | 125,954 | -26.1% | 0.02% | -12.5% |
| Q2 2013 | $4,579,000 | – | 170,396 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |